Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...

is off-patent and only the FDA’s tough approach to copies of therapies combining an inhaler and a drug is keeping competitors at bay. The new US indication for Trelegy is for the long-term ...

But the CHMP said that while trial evidence showed Trelegy improved lung function, it could not approve the drug because of the lack of evidence to show it cut the risk of exacerbations.